Review article · 2024 · Open access
Diagnosis and management of inflammatory bowel disease
Journal of Evidence-Based Medicine, 17(2), 409–433 · Published 1 June 2024 · DOI 10.1111/jebm.12626
In brief
“Diagnosis and management of inflammatory bowel disease” is a 2024 review article by Lili Li and 5 co-authors, published in Journal of Evidence-Based Medicine. OpenAlex counts 58 citations as of 22 November 2026, which puts it in the top 3% of works published in 2024 by citations. It is open access: the full text is free to read at Journal of Evidence-Based Medicine.
- Citations
- 58
- Most cited in
- 2025 (26)
- Field-weighted impact
- 3.24
- References
- 227
- Authors
- 6
Abstract
Inflammatory bowel disease (IBD) is a chronic and relapsing immune-mediated disease of the gastrointestinal tract with a gradually increasing global incidence and prevalence. A prolonged course of IBD leads to a decline in patient quality of life and the creation of a substantial economic burden on society. Owing to the lack of specific diagnostic markers, the diagnosis of IBD still needs a gold standard based on a combination of clinical manifestations, imaging, laboratory, and endoscopic results. Accordingly, the current goals of IBD treatment are to alleviate clinical symptoms and reduce recurrence rates. Therefore, it is imperative to develop a standard set of procedures to diagnose and treat IBD. In this review, we summarize prominent and emerging studies, outline classical and contemporary approaches to diagnosing and managing IBD, and integrate multiple guidelines. Furthermore, we propose the possibility of establishing an early and comprehensive diagnostic workflow and personalized management strategy in the future. We aim to enhance the quality and standardization of diagnostic and treatment procedures for IBD.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Li, L., Cheng, R., Wu, Y., Lin, H., Gan, H., & Zhang, H. (2024). Diagnosis and management of inflammatory bowel disease. Journal of Evidence-Based Medicine, 17(2), 409–433. https://doi.org/10.1111/jebm.12626
MLA 9
Li, Lili, et al. “Diagnosis and management of inflammatory bowel disease.” Journal of Evidence-Based Medicine, vol. 17, no. 2, 2024, pp. 409–433. https://doi.org/10.1111/jebm.12626.
Chicago
Li, Lili, Rui Cheng, Yushan Wu, Hao Lin, Huatian Gan, and Hu Zhang. 2024. “Diagnosis and management of inflammatory bowel disease.” Journal of Evidence-Based Medicine 17 (2): 409–433. https://doi.org/10.1111/jebm.12626.
Harvard
Li, L. et al. (2024) ‘Diagnosis and management of inflammatory bowel disease’, Journal of Evidence-Based Medicine, 17(2), pp. 409–433. doi:10.1111/jebm.12626.
IEEE
L. Li, R. Cheng, Y. Wu, H. Lin, H. Gan, and H. Zhang, “Diagnosis and management of inflammatory bowel disease,” Journal of Evidence-Based Medicine, vol. 17, no. 2, pp. 409–433, 2024, doi: 10.1111/jebm.12626.
BibTeX
@article{li2024diagnosis,
title = {{Diagnosis and management of inflammatory bowel disease}},
author = {Li, Lili and Cheng, Rui and Wu, Yushan and Lin, Hao and Gan, Huatian and Zhang, Hu},
journal = {Journal of Evidence-Based Medicine},
year = {2024},
volume = {17},
number = {2},
pages = {409--433},
doi = {10.1111/jebm.12626},
url = {https://doi.org/10.1111/jebm.12626}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 6 | |
| 2025 | 26 | |
| 2026 | 26 |
Its field-weighted citation impact is 3.24: it has been cited 3.24 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- inflammatory bowel disease
- diagnosis
- management
- diagnostic workflow
- personalized treatment
- endoscopic diagnosis
- imaging
- laboratory biomarkers
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Li, L., Cheng, R., Wu, Y., Lin, H., Gan, H., & Zhang, H. (2024). Diagnosis and management of inflammatory bowel disease. Journal of Evidence-Based Medicine, 17(2), 409–433. https://doi.org/10.1111/jebm.12626
How many times has this paper been cited?
58 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Evidence-Based Medicine: sign in and open the PDF from this page.
Who wrote this paper?
Lili Li, Rui Cheng, Yushan Wu, Hao Lin, Huatian Gan, Hu Zhang.
What is the DOI of this paper?
10.1111/jebm.12626, permanently at https://doi.org/10.1111/jebm.12626. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.